AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24581132 — intervention group
Group type: COMPARATOR
Intervention: Group A and Group B (comparison of different remifentanil levels)
Number of subjects: 48
Study 22609117 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifactorial intervention program (individual advice, information leaflet, physical exercise workshop, home visits)
Number of subjects: 404
Study 22609117 — intervention group
Group type: COMPARATOR
Intervention: Brief individual advice and information leaflet (Control Group)
Number of subjects: 404
Study 22609117 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifactorial intervention program
Number of subjects: 404
Study 20714767 — intervention group
Group type: EXPERIMENTAL
Intervention: Ice-slush beverage (ISB)
Number of subjects: 10
Study 20714767 — intervention group
Group type: COMPARATOR
Intervention: Cool liquid beverage (CLB)
Number of subjects: 10
Study 18843459 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin 20 mg bid
Number of subjects: 832
Study 18843459 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin 20 mg qd
Number of subjects: 832
Study 18843459 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin 40 mg qd
Number of subjects: 832
Study 18843459 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 832
Study 18843459 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment groups (including placebo)
Number of subjects: 832
Study 16091854 — intervention group
Group type: EXPERIMENTAL
Intervention: Going Places Program
Number of subjects: 1484
Study 11821273 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual misoprostol (400 microg)
Number of subjects: 40
Study 12153552 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan 50 mg day-1
Number of subjects: 8
Study 12153552 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 12153552 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects
Number of subjects: 8
Study 9649261 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg finasteride daily for 9 months
Number of subjects: 40
Study 9649261 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 40
Study 8034082 — intervention group
Group type: EXPERIMENTAL
Intervention: Four fresh embryos transferred (group 1)
Number of subjects: 56
Study 8034082 — intervention group
Group type: COMPARATOR
Intervention: Two fresh embryos transferred and two frozen (group 2)
Number of subjects: 56
Study 2688726 — intervention group
Group type: EXPERIMENTAL
Intervention: Fissure sealants
Number of subjects: 3005
Study 2688726 — intervention group
Group type: COMPARATOR
Intervention: General dental practitioners
Number of subjects: 3005
Study 30355640 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher air leak measurements (≥100 mL/min on day 1)
Number of subjects: 81
Study 30355640 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily digital air leak measurements
Number of subjects: 81
Study 28554908 — intervention group
Group type: EXPERIMENTAL
Intervention: B-type natriuretic peptide (BNP)
Number of subjects: 5525
Study 28554908 — intervention group
Group type: EXPERIMENTAL
Intervention: N-terminal prohormone B-type natriuretic peptide (NT-proBNP)
Number of subjects: 5525
Study 28554908 — intervention group
Group type: EXPERIMENTAL
Intervention: BNP or NT-proBNP
Number of subjects: 5525
Study 26391136 — intervention group
Group type: EXPERIMENTAL
Intervention: Contact Force (CF) technology
Number of subjects: 1428
Study 26391136 — intervention group
Group type: COMPARATOR
Intervention: Conventional catheter
Number of subjects: 1428
Study 23737922 — intervention group
Group type: EXPERIMENTAL
Intervention: Student peer teacher
Number of subjects: 123
Study 23737922 — intervention group
Group type: EXPERIMENTAL
Intervention: Senior lecturer
Number of subjects: 123
Study 23737922 — intervention group
Group type: COMPARATOR
Intervention: Control group (students who never examined a child before)
Number of subjects: 123
Study 23737922 — intervention group
Group type: EXPERIMENTAL
Intervention: Practical skills OSCE
Number of subjects: 123
Study 23737922 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer teaching evaluation
Number of subjects: 123
Study 21907539 — intervention group
Group type: EXPERIMENTAL
Intervention: Disengagement from threat
Number of subjects: 0
Study 21907539 — intervention group
Group type: EXPERIMENTAL
Intervention: Engagement towards non-threat
Number of subjects: 0
Study 21907539 — intervention group
Group type: EXPERIMENTAL
Intervention: Disengagement from threat and re-engagement towards non-threat
Number of subjects: 0
Study 21907539 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 0
Study 21067018 — intervention group
Group type: EXPERIMENTAL
Intervention: Tablet Ciprofloxacin 500 mg
Number of subjects: 300
Study 21067018 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection Ceftriaxone 500 mg
Number of subjects: 300
Study 21067018 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection Spectinomycin 2 gm
Number of subjects: 300
Study 16520452 — intervention group
Group type: EXPERIMENTAL
Intervention: Audiotape questionnaire
Number of subjects: 497
Study 16520452 — intervention group
Group type: COMPARATOR
Intervention: Written questionnaire
Number of subjects: 497
Study 14600930 — intervention group
Group type: EXPERIMENTAL
Intervention: Solid meal (100 g ground beef labelled with 25 MBq (99m)Tc sulphur colloid)
Number of subjects: 23
Study 14600930 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid meal (150 ml 10% glucose drink labelled with 8 MBq (67)Ga citrate)
Number of subjects: 23
Study 10680096 — intervention group
Group type: EXPERIMENTAL
Intervention: Autogenic drainage (AD)
Number of subjects: 30
Study 10680096 — intervention group
Group type: COMPARATOR
Intervention: Active cycle of breathing techniques (ACBT)
Number of subjects: 30
Study 9342984 — intervention group
Group type: EXPERIMENTAL
Intervention: Labetalol hydrochloride 0.3 mg/kg 3 minutes before induction and 0.15 mg/kg 2 minutes prior to suspension of the larynx
Number of subjects: 30
Study 9342984 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmolol hydrochloride 500 micrograms/kg 3 minutes prior to induction and continuous infusion of 300 micrograms/kg during surgery
Number of subjects: 30
Study 9342984 — intervention group
Group type: COMPARATOR
Intervention: Control group received only anesthetic drugs
Number of subjects: 30
Study 8409786 — intervention group
Group type: EXPERIMENTAL
Intervention: Chiropractic Biophysics Technique (CBP)
Number of subjects: 65
Study 31736357 — intervention group
Group type: EXPERIMENTAL
Intervention: Udenafil 87.5 mg twice daily
Number of subjects: 400
Study 31736357 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 400
Study 30204655 — intervention group
Group type: EXPERIMENTAL
Intervention: AIRfr (airflow-restriction mask)
Number of subjects: 10
Study 28366047 — intervention group
Group type: EXPERIMENTAL
Intervention: Video modeling parental training intervention delivered over 22 weeks.
Number of subjects: 67
Study 28366047 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned).
Number of subjects: 67
Study 26009913 — intervention group
Group type: EXPERIMENTAL
Intervention: Conical interface (CI)
Number of subjects: 141
Study 26009913 — intervention group
Group type: EXPERIMENTAL
Intervention: Flat-to-flat interface (FI)
Number of subjects: 141
Study 26009913 — intervention group
Group type: EXPERIMENTAL
Intervention: Platform switch interface (PS)
Number of subjects: 141
Study 23218805 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Bias Modification (CBM)
Number of subjects: 509
Study 23218805 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (Control)
Number of subjects: 509
Study 22016911 — intervention group
Group type: EXPERIMENTAL
Intervention: GUM Summit+Compact Head
Number of subjects: 24
Study 22016911 — intervention group
Group type: EXPERIMENTAL
Intervention: GUM Technique Deep Clean Compact Head
Number of subjects: 24
Study 22016911 — intervention group
Group type: COMPARATOR
Intervention: Oral‐B Indicator 35 (compact head)
Number of subjects: 24
Study 20120794 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple micronutrient supplements
Number of subjects: 0
Study 20120794 — intervention group
Group type: COMPARATOR
Intervention: Iron with or without folic acid
Number of subjects: 0
Study 17091657 — intervention group
Group type: EXPERIMENTAL
Intervention: Popsicle
Number of subjects: 0
Study 17091657 — intervention group
Group type: COMPARATOR
Intervention: Toy
Number of subjects: 0
Study 14967569 — intervention group
Group type: EXPERIMENTAL
Intervention: isokinetic techniques
Number of subjects: 17
Study 14967569 — intervention group
Group type: COMPARATOR
Intervention: standard physiotherapy
Number of subjects: 17
Study 11554217 — intervention group
Group type: EXPERIMENTAL
Intervention: ArginMax
Number of subjects: 77
Study 11554217 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study 9598520 — intervention group
Group type: EXPERIMENTAL
Intervention: Olympus prototype model A2186 resectoscope loop
Number of subjects: 226
Study 9598520 — intervention group
Group type: COMPARATOR
Intervention: Conventional resectoscope loop
Number of subjects: 226
Study 7841660 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette smoke exposure
Number of subjects: 57
Study 3212403 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunosuppressive drug therapy with long-term plasmapheresis
Number of subjects: 15
Study 3212403 — intervention group
Group type: COMPARATOR
Intervention: Immunosuppressive drug therapy
Number of subjects: 15
Study 30624250 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile device application for PFMT
Number of subjects: 21
Study 30624250 — intervention group
Group type: COMPARATOR
Intervention: Control group with written instructions
Number of subjects: 21
Study 30029486 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week exercise plus compensatory eating avoidance program (CEAP; n = 24)
Number of subjects: 45
Study 30029486 — intervention group
Group type: COMPARATOR
Intervention: 8-week exercise intervention only (control; n = 21)
Number of subjects: 45
Study 27283367 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy (CBT) plus narrow-band UVB phototherapy for 8 weeks
Number of subjects: 40
Study 27283367 — intervention group
Group type: COMPARATOR
Intervention: Narrow-band UVB phototherapy for 8 weeks (control group)
Number of subjects: 40
Study 25703666 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGM‐CSF hydrogel
Number of subjects: 21
Study 25703666 — intervention group
Group type: COMPARATOR
Intervention: mupirocin ointment
Number of subjects: 21
Study 24335927 — intervention group
Group type: EXPERIMENTAL
Intervention: Kegel exercise intervention group
Number of subjects: 12
Study 24335927 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 12
Study 20461001 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil infusion (target concentrations: 4-9 ng/ml; infusion rates: 0.17-9 ng x ml x min)
Number of subjects: 10
Study 20461001 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil infusion with low-dose propofol
Number of subjects: 10
Study 20461001 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation study at varying remifentanil infusion speeds
Number of subjects: 10
Study 17901910 — intervention group
Group type: EXPERIMENTAL
Intervention: Polypropylene mesh surgery
Number of subjects: 90
Study 17901910 — intervention group
Group type: COMPARATOR
Intervention: Site-specific surgery
Number of subjects: 90
Study 16390895 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine or Nortriptyline
Number of subjects: 175
Study 14638885 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyridostigmine 60 mg four times a day for 14 weeks
Number of subjects: 67
Study 14638885 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study 10822283 — intervention group
Group type: EXPERIMENTAL
Intervention: Extruded dry beans (110 g/day)
Number of subjects: 22
Study 10822283 — intervention group
Group type: COMPARATOR
Intervention: Control diet (no dry beans)
Number of subjects: 22
Study 8864326 — intervention group
Group type: EXPERIMENTAL
Intervention: Lignocaine + Clonidine
Number of subjects: 4
Study 8864326 — intervention group
Group type: EXPERIMENTAL
Intervention: Lignocaine + Adrenaline
Number of subjects: 4
Study 8864326 — intervention group
Group type: EXPERIMENTAL
Intervention: Lignocaine + Adrenaline + Clonidine
Number of subjects: 4
Study 8864326 — intervention group
Group type: COMPARATOR
Intervention: Plain Lignocaine
Number of subjects: 4
Study 1623914 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen (25 mg)
Number of subjects: 12
Study 1623914 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen (200 mg)
Number of subjects: 12
Study 1623914 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (500 mg)
Number of subjects: 12
Study 6379871 — intervention group
Group type: EXPERIMENTAL
Intervention: Broncho-Vaxom
Number of subjects: 75
Study 6379871 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 75
Study 31701568 — intervention group
Group type: EXPERIMENTAL
Intervention: High scores on General Attractiveness Subscale for sunbathing
Number of subjects: 3000
Study 31701568 — intervention group
Group type: EXPERIMENTAL
Intervention: Age 18-25 years for sunbed use
Number of subjects: 3000
Study 31701568 — intervention group
Group type: EXPERIMENTAL
Intervention: High scores on General Attractiveness Subscale for sunbed use
Number of subjects: 3000
Study 31701568 — intervention group
Group type: EXPERIMENTAL
Intervention: Low risk perception of UVR
Number of subjects: 3000
Study 31701568 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk perception of UVR
Number of subjects: 3000
Study 30892676 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine infusion (Group K)
Number of subjects: 100
Study 30892676 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine infusion (Group L)
Number of subjects: 100
Study 30892676 — intervention group
Group type: COMPARATOR
Intervention: Control group (0.9% sodium chloride infusion)
Number of subjects: 100
Study 28183568 — intervention group
Group type: EXPERIMENTAL
Intervention: Play dough (group PD)
Number of subjects: 104
Study 28183568 — intervention group
Group type: COMPARATOR
Intervention: Control group (group C)
Number of subjects: 104
Study 26242010 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP + SZ
Number of subjects: 64
Study 26242010 — intervention group
Group type: COMPARATOR
Intervention: SRP + placebo
Number of subjects: 64
Study 24342500 — intervention group
Group type: EXPERIMENTAL
Intervention: ACLR
Number of subjects: 59
Study 24342500 — intervention group
Group type: EXPERIMENTAL
Intervention: ACLD
Number of subjects: 59
Study 24342500 — intervention group
Group type: COMPARATOR
Intervention: CONT
Number of subjects: 59
Study 21996573 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective supraomohyoid neck dissection with level IIb
Number of subjects: 57
Study 21996573 — intervention group
Group type: COMPARATOR
Intervention: Selective supraomohyoid neck dissection without level IIb
Number of subjects: 57
Study 21996573 — intervention group
Group type: EXPERIMENTAL
Intervention: EMG or NCS data on trapezius muscle activity
Number of subjects: 57
Study 21996573 — intervention group
Group type: EXPERIMENTAL
Intervention: University of Washington quality of life scale (UWQoLv4)
Number of subjects: 57
Study 21996573 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck dissection impairment index (NDII)
Number of subjects: 57
Study 21996573 — intervention group
Group type: EXPERIMENTAL
Intervention: Range of movement
Number of subjects: 57
Study 19541265 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekend atropine plus full spectacle correction for the sound eye
Number of subjects: 100
Study 19541265 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekend atropine plus plano lens
Number of subjects: 100
Study 19541265 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekend atropine
Number of subjects: 100
Study 19541265 — intervention group
Group type: COMPARATOR
Intervention: 2 hours of daily patching
Number of subjects: 100
Study 17382157 — intervention group
Group type: EXPERIMENTAL
Intervention: Local anesthetic
Number of subjects: 994
Study 17382157 — intervention group
Group type: COMPARATOR
Intervention: Placebo or nothing
Number of subjects: 994
Study 15314339 — intervention group
Group type: EXPERIMENTAL
Intervention: Aroma-sitz bath group
Number of subjects: 0
Study 15314339 — intervention group
Group type: EXPERIMENTAL
Intervention: Aroma-soap application group
Number of subjects: 0
Study 15314339 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 11098943 — intervention group
Group type: EXPERIMENTAL
Intervention: Dispatcher-assisted CPR with chest compression only
Number of subjects: 520
Study 11098943 — intervention group
Group type: COMPARATOR
Intervention: Standard instructions for airway maintenance ventilation and chest compression (control)
Number of subjects: 520
Study 9262035 — intervention group
Group type: EXPERIMENTAL
Intervention: K every 24 hr
Number of subjects: 152
Study 9262035 — intervention group
Group type: EXPERIMENTAL
Intervention: K every 12 hr
Number of subjects: 152
Study 9262035 — intervention group
Group type: COMPARATOR
Intervention: MSC every 12 hr
Number of subjects: 152
Study 8316267 — intervention group
Group type: EXPERIMENTAL
Intervention: Directional atherectomy
Number of subjects: 274
Study 8316267 — intervention group
Group type: COMPARATOR
Intervention: Balloon angioplasty
Number of subjects: 274
Study 3333162 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline (1200 mg/day per os, Trental 400 t.i.d.)
Number of subjects: 60
Study 3333162 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 3333162 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline
Number of subjects: 60
Study 30513727 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 cups of coffee/day
Number of subjects: 47
Study 30513727 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 cups of coffee/day
Number of subjects: 47
Study 30513727 — intervention group
Group type: COMPARATOR
Intervention: No coffee consumption (control phase)
Number of subjects: 47
Study 25520035 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotically assisted body weight supported treadmill training (RABWSTT)
Number of subjects: 18
Study 25520035 — intervention group
Group type: COMPARATOR
Intervention: Home stretching program (HSP)
Number of subjects: 18
Study 25002731 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone (MP) 16 mg twice daily
Number of subjects: 50
Study 25002731 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 50
Study 22943199 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab/MTX in late RA
Number of subjects: 3
Study 22943199 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab/MTX in early RA
Number of subjects: 3
Study 22943199 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate and methylprednisolone in early RA (control group)
Number of subjects: 3
Study 20691042 — intervention group
Group type: EXPERIMENTAL
Intervention: Six-months physical training with active and/or assisted cycling training equipment for ambulant and recently wheelchair‐dependent boys with DMD.
Number of subjects: 40
Study 20691042 — intervention group
Group type: EXPERIMENTAL
Intervention: Six-months physical training program consisting of computer‐assisted training and functional training with arm support for boys with DMD confined to a wheelchair.
Number of subjects: 40
Study 18655528 — intervention group
Group type: EXPERIMENTAL
Intervention: Intense combined 3-month familial dietary-behavioral-physical activity intervention
Number of subjects: 22
Study 15957666 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensified screening using Timeline Followback (TLFB) interview and Alcohol Use Disorder Inventory Test (AUDIT)
Number of subjects: 303
Study 15957666 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensified screening using AUDIT
Number of subjects: 303
Study 15957666 — intervention group
Group type: COMPARATOR
Intervention: Regular antenatal care (control)
Number of subjects: 303
Study 15320473 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparins (LMWH)
Number of subjects: 0
Study 15320473 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated heparin (UH)
Number of subjects: 0
Study 10958880 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural rubber latex condom
Number of subjects: 54
Study 10958880 — intervention group
Group type: COMPARATOR
Intervention: Polyurethane condom
Number of subjects: 54
Study 10958880 — intervention group
Group type: EXPERIMENTAL
Intervention: New non-latex (SEBS) condom
Number of subjects: 54
Study 8962549 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy for acute myocardial infarction
Number of subjects: 0
Study 1835229 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatitis B immunoglobulin (HBIg) and recombinant hepatitis B vaccine (HBvaxDNA) with an intensive schedule (0, 1 months for HBIg; 0, 1, 2, 6 months for vaccine)
Number of subjects: 175
Study 1835229 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatitis B immunoglobulin (HBIg) and recombinant hepatitis B vaccine (HBvaxDNA) for males
Number of subjects: 175
Study 1835229 — intervention group
Group type: COMPARATOR
Intervention: Control group (hospital personnel immunized with HBvaxDNA without HBIg, regular schedule 0, 1, 6 months)
Number of subjects: 175
Study 1835229 — intervention group
Group type: EXPERIMENTAL
Intervention: Geometric mean titre for female patients
Number of subjects: 175
Study 1835229 — intervention group
Group type: COMPARATOR
Intervention: Geometric mean titre for female controls
Number of subjects: 175
Study 1835229 — intervention group
Group type: EXPERIMENTAL
Intervention: Geometric mean titre for male patients
Number of subjects: 175
Study 1835229 — intervention group
Group type: COMPARATOR
Intervention: Geometric mean titre for male controls
Number of subjects: 175
Study 6188917 — intervention group
Group type: EXPERIMENTAL
Intervention: metoprolol (average 179 mg/day)
Number of subjects: 36
Study 6188917 — intervention group
Group type: EXPERIMENTAL
Intervention: pindolol (average 12 mg/day)
Number of subjects: 36
Study 30316694 — intervention group
Group type: EXPERIMENTAL
Intervention: Video education
Number of subjects: 90
Study 30316694 — intervention group
Group type: EXPERIMENTAL
Intervention: Written education
Number of subjects: 90
Study 30316694 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 90
Study 29866127 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention based on the RANAS model
Number of subjects: 900